Abstract
This study compared noninvasive pressure support ventilation (NIPSV) and continuous positive airway pressure (CPAP) in patients with acute hypercapnic pulmonary edema with regard to resolution time. Randomized prospective study in an emergency department. We randomly assigned 36 patients with respiratory failure due to acute pulmonary edema and arterial hypercapnia (PaCO(2) >45 mmHg) to NIPSV (n=18) or CPAP through a face mask (n=18). Electrocardiographic and physiological measurements were made over 36 h. There was no difference in resolution time defined as clinical improvement with a respiratory rate of fewer than 30 breaths/min and SpO(2)of 96% or more between CPAP and NIPSV groups. Arterial carbon dioxide tension was significantly decreased after 1 h of ventilation (CPAP, 60.5+/-13.6 to 42.8+/-4.9 mmHg; NIPSV, 65.7+/-13.6 to 44.0+/-5.5 mmHg); respective improvements were seen in pH (CPAP, 7.22+/-0.11 to 7.37+/-0.04; NIPSV, 7.19+/-0.11 to 7.38+/-0.04), SpO(2) (CPAP, 86.9+/-3.7% to 95.1+/-2.6%; NIPSV, 83.7+/-6.6% to 96.0+/-2.9%), and respiratory rate (CPAP, 37.9+/-4.5 to 21.3+/-5.1 breaths/min; NIPSV, 39.8+/-4.4 to 21.2+/-4.6 breaths/min). No significant differences were seen with regards to endotracheal intubation and in-hospital mortality. NIPSV proved as effective as CPAP in the treatment of patients with acute pulmonary edema and hypercapnia but did not improve resolution time.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.